Artículo original
Uso de recursos sanitarios y costes asociados en pacientes ancianos vulnerables no institucionalizados con vejiga hiperactiva tratados con antimuscarínicos en la práctica médica habitual
Use of health care resources and associated costs in non-institutionalized vulnerable elders with overactive bladder treated with antimuscarinic agents in the usual medical practice
A. Sicras-Mainara,
, J. Rejas-Gutiérrezb, R. Navarro-Artiedac, A. Aguado-Jodard, A. Ruíz-Torrejóne
Autor para correspondencia
a Dirección de Planificación, Badalona Serveis Assistencials SA, Badalona, Barcelona, España
b Health Economics and Outcomes Research, Pfizer SLU, Alcobendas, Madrid, España
c Documentación Médica, Hospital Germans Trias i Pujol, Badalona, Barcelona, España
d CAP Sagrada Familia, Consorci Sanitari Integral, Barcelona, España
e Dirección de Atención Primaria, Servicio Balear de Salud, Ib-Salut, Mallorca, España
Leído
573
Vecesse ha leído el artículo
239
Total PDF
334
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 0 | 6 | 6 |
| 2025 10 | 0 | 4 | 4 |
| 2025 9 | 0 | 4 | 4 |
| 2025 8 | 0 | 4 | 4 |
| 2025 7 | 0 | 2 | 2 |
| 2025 5 | 0 | 9 | 9 |
| 2025 4 | 0 | 11 | 11 |
| 2025 2 | 0 | 5 | 5 |
| 2025 1 | 0 | 7 | 7 |
| 2024 12 | 0 | 3 | 3 |
| 2024 10 | 0 | 10 | 10 |
| 2024 9 | 0 | 11 | 11 |
| 2024 8 | 0 | 6 | 6 |
| 2024 7 | 0 | 1 | 1 |
| 2024 6 | 0 | 4 | 4 |
| 2024 4 | 0 | 1 | 1 |
| 2024 3 | 0 | 1 | 1 |
| 2024 2 | 0 | 1 | 1 |
| 2024 1 | 0 | 2 | 2 |
| 2023 12 | 0 | 9 | 9 |
| 2023 9 | 0 | 3 | 3 |
| 2023 8 | 0 | 1 | 1 |
| 2023 7 | 0 | 1 | 1 |
| 2023 6 | 0 | 3 | 3 |
| 2023 5 | 0 | 2 | 2 |
| 2023 3 | 0 | 1 | 1 |
| 2023 2 | 0 | 2 | 2 |
| 2022 1 | 0 | 1 | 1 |
| 2022 12 | 0 | 1 | 1 |
| 2022 11 | 0 | 1 | 1 |
| 2022 10 | 0 | 2 | 2 |
| 2022 8 | 0 | 1 | 1 |
| 2022 6 | 0 | 2 | 2 |
| 2022 3 | 0 | 5 | 5 |
| 2021 1 | 0 | 1 | 1 |
| 2021 12 | 0 | 3 | 3 |
| 2021 10 | 0 | 1 | 1 |
| 2021 8 | 0 | 1 | 1 |
| 2021 7 | 0 | 1 | 1 |
| 2021 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 1 | 1 |
| 2020 8 | 0 | 2 | 2 |
| 2020 5 | 0 | 1 | 1 |
| 2020 4 | 0 | 1 | 1 |
| 2020 2 | 0 | 3 | 3 |
| 2020 1 | 0 | 1 | 1 |
| 2019 12 | 0 | 2 | 2 |
| 2019 11 | 0 | 1 | 1 |
| 2019 9 | 0 | 1 | 1 |
| 2019 7 | 0 | 6 | 6 |
| 2019 5 | 0 | 4 | 4 |
| 2018 3 | 56 | 0 | 56 |
| 2018 2 | 7 | 1 | 8 |
| 2018 1 | 24 | 1 | 25 |
| 2017 12 | 16 | 1 | 17 |
| 2017 11 | 10 | 0 | 10 |
| 2017 10 | 11 | 1 | 12 |
| 2017 9 | 9 | 4 | 13 |
| 2017 8 | 18 | 3 | 21 |
| 2017 7 | 14 | 2 | 16 |
| 2017 6 | 11 | 6 | 17 |
| 2017 5 | 19 | 2 | 21 |
| 2017 4 | 20 | 1 | 21 |
| 2017 3 | 18 | 36 | 54 |
| 2017 2 | 13 | 1 | 14 |
| 2016 1 | 0 | 3 | 3 |
| 2016 12 | 24 | 6 | 30 |
| 2016 11 | 27 | 4 | 31 |
| 2016 10 | 30 | 6 | 36 |
| 2015 10 | 1 | 0 | 1 |
| 2015 9 | 0 | 1 | 1 |
| 2015 4 | 1 | 1 | 2 |
| 2015 2 | 1 | 0 | 1 |
| 2014 10 | 4 | 1 | 5 |
Mostrar todo
